Ernexa Therapeutics Inc. (ERNA)

Ernexa Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1.73	7.58	11.45	16.99	1.63
Cash & Short-Term Investments	1.73	7.58	11.45	16.99	1.63
Cash Growth	-77.18%	-33.82%	-32.61%	942.02%	-67.50%
Other Receivables	0.44	0.43	0.95	0.68	-
Receivables	0.44	0.43	0.95	0.68	-
Prepaid Expenses	0.19	1.6	1.28	1.1	0.1
Total Current Assets	2.35	9.6	13.68	18.77	1.73
Property, Plant & Equipment	0.76	33.27	1.27	3.24	2.69
Long-Term Investments	-	-	0.06	1	-
Goodwill	2.04	2.04	2.04	2.04	2.04
Long-Term Deferred Charges	-	-	-	5.99	5.99
Other Long-Term Assets	0.12	4.22	5.23	0.49	0.45
Total Assets	5.27	49.13	22.28	31.53	12.91
Accounts Payable	1.72	1.07	1.62	1.76	1.28
Accrued Expenses	1.01	2.88	4.1	1.01	1.05
Short-Term Debt	-	-	-	-	0.41
Current Portion of Long-Term Debt	-	-	-	-	0.12
Current Portion of Leases	0.21	2.22	0.3	0.43	0.27
Current Income Taxes Payable	0	0	-	-	-
Current Unearned Revenue	-	0.19	-	-	-
Other Current Liabilities	-	0.22	1.64	0.49	-
Total Current Liabilities	2.94	6.57	7.65	3.68	3.13
Long-Term Debt	-	6.77	-	-	0.19
Long-Term Leases	0.48	32.85	0.89	2.3	1.91
Long-Term Unearned Revenue	-	0.39	-	-	-
Other Long-Term Liabilities	0.15	0.31	1.63	0.05	0.02
Total Liabilities	3.57	46.9	10.17	6.02	5.25
Common Stock	0.26	0.03	0.03	0.01	25.8
Additional Paid-In Capital	232.98	189.19	177.38	166.19	-
Retained Earnings	-231.54	-186.98	-165.3	-140.7	-18.14
Total Common Equity	1.7	2.23	12.11	25.5	7.66
Shareholders' Equity	1.7	2.23	12.11	25.5	7.66
Total Liabilities & Equity	5.27	49.13	22.28	31.53	12.91
Total Debt	0.68	41.84	1.18	2.72	2.9
Net Cash (Debt)	1.05	-34.27	10.26	14.26	-1.27
Net Cash Growth	-	-	-28.03%	-	-
Net Cash Per Share	0.08	-6.45	3.36	6.59	-1.44
Filing Date Shares Outstanding	52.24	5.41	5.13	2.87	0.88
Total Common Shares Outstanding	51.39	5.41	5.13	2.6	0.88
Working Capital	-0.59	3.03	6.03	15.09	-1.39
Book Value Per Share	0.03	0.41	2.36	9.80	8.68
Tangible Book Value	-0.34	0.19	10.06	23.46	5.62
Tangible Book Value Per Share	-0.01	0.03	1.96	9.02	6.37
Machinery	0.26	0.33	0.27	0.41	0.3
Leasehold Improvements	-	0.27	-	0.46	0.41

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q